Novartis raises 2023 forecast, maps out Sandoz spin-off
By Ludwig Burger FRANKFURT (Reuters) -Novartis on Tuesday raised its full-year earnings forecast for the second time on strong drug…
By Ludwig Burger FRANKFURT (Reuters) -Novartis on Tuesday raised its full-year earnings forecast for the second time on strong drug…
By Chuck Mikolajczak NEW YORK (Reuters) – U.S. stocks ended higher to kick off the trading week on Monday, buoyed…
By Nathan Gomes (Reuters) -Ford deepened a price war in the electric-vehicle industry on Monday by slashing the prices of…
By Doyinsola Oladipo (Reuters) -Marriott International said on Monday it entered a 20-year licensing agreement that will allow its loyalty…
By Chibuike Oguh NEW YORK (Reuters) -Shares of AT&T Inc fell nearly 7% to hit their lowest level in thirty…
By Ross Kerber (Reuters) – The world’s top asset manager BlackRock said it will offer proxy voting choices to U.S.…
Bill Ackman, the mastermind behind Pershing Square, has made an audacious forecast for the 2024 Republican primary race, foreseeing…
By Aniruddha Ghosh and Roshan Abraham (Reuters) -J.P.Morgan, Morgan Stanley and Citigroup trimmed China’s growth forecast for 2023 after the…
By Raphael Satter WASHINGTON (Reuters) -Microsoft said on Friday that Chinese hackers misappropriated one of its digital keys and used…